Market Tracker

08/22 5:16pm ET

Progenics Pharmaceuticals Inc (NASDAQ:PGNX)

5.75
Delayed Data
As of 4:00pm ET
 -0.01 / -0.17%
Today’s Change
4.60
Today|||52-Week Range
11.72
-33.45%
Year-to-Date
Oversold Small-Cap Biotech Names
Aug 18 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close5.76
Today’s open5.80
Day’s range5.74 - 5.89
Volume1,034,283
Average volume (3 months)929,528
Market cap$404.8M
Dividend yield--
Data as of 4:00pm ET, 08/22/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-693.33%
Earnings growth (next 5 years)+7.00%
Revenue growth (last year)+700.24%
P/E ratioNM
Price/Sales8.73
Price/Book3.86

Competitors

 Today’s
change
Today’s
% change
SNNASienna Biopharmaceut...+2.00+9.76%
AVEOAveo Pharmaceuticals...+0.17+5.09%
DEPODepomed Inc-0.22-3.54%
CARACara Therapeutics In...+0.31+2.41%
Data as of 4:14pm ET, 08/22/2017

Financials

Next reporting dateNovember 9, 2017
EPS forecast (this quarter)-$0.23
Annual revenue (last year)$69.4M
Annual profit (last year)$10.8M
Net profit margin15.56%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Mark Robert Baker
CFO, Principal Accounting Officer &
Senior VP
Patrick Fabbio
Corporate headquarters
Tarrytown, New York

Forecasts